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ABSTRACT
GH4CI cells are a clonal strain of rat pituitary cells that synthesize and secrete
prolactin and growth hormone . Chronic treatment (longer than 24 h) of GH4CI
cells with epidermal growth factor (EGF) (10-8 M) decreased by 30-40% both the
rate of cell proliferation and the plateau density reached by cultures . Inhibition of
cell proliferation was accompanied by a change in cellular morphology from a
spherical appearance to an elongated flattened shape and by a40-60% increase in
cell volume . These actions of EGF were qualitatively similar to those of the
hypothalamic tripeptide thyrotropin-releasing hormone (TRH) (10- ' M) which
decreased the rate of cell proliferation by 10-20% and caused a 15% increase in
cell volume. The presence of supramaximal concentrations of both EGF (10-A M)
and TRH (10-' M) resulted in greater effects on cell volume and cell multiplication
than either peptide alone . EGF also altered hormone production by GH4CI cells
in the same manner as TRH . Treatment of cultures with 10-A M EGF for 2-6 d
increased prolactin synthesis five- to ninefold compared to a two- to threefold
stimulation by 10- ' M TRH . Growth hormone production by the same cultures
was inhibited 40% by EGF and 15% by TRH . The half-maximal effect ofEGF to
increase prolactin synthesis, decrease growth hormone production, and inhibit cell
proliferation occurred at a concentration of 5 x10-" M . Insulin and multiplication
stimulating activity, two other growth factors tested, did not alter cell proliferation,
cell morphology, or hormone production by GH4C 1 cells, indicating the specificity
of the EGF effect . Fibroblast growth factor, however, had effects similar to those
of EGF and TRH . Of five pituitary cell strains tested, all but one responded to
chronic EGF treatment with specifically altered hormone production . Acute
treatment (30 min) of GH4CI cells with 10-' M EGF caused a 30% enhancement
of prolactin release compared to a greater than twofold increase caused by 10-'M
TRH . Therefore, although EGF and TRH have qualitatively similar effects on
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and cell proliferation chronically are distinct .
GH t cells are clonal strains of rat pituitary tumor
cells that synthesize and secrete prolactin and
growth hormone (28, 30) . These cells have retained
many of the differentiated properties of normal
pituitary cells during 14 yr in continuous culture
and have proved a valuable model for studying
regulatory factors which control pituitary cell
function in the intact animal . Forexample, effects
of the hypothalamic tripeptide thyrotropin-releas-
ing hormone (TRH) on the synthesis or release of
pituitary hormones other than thyrotropin hadnot
been described until Tashjian et al . (31) reported
a direct stimulatory effect of TRH on prolactin
production by GH 3 cells, Prolactin-releasing activ-
ity of TRH was then extensively documented in
many species both in vivo (5, 21) and in vitro (35) .
Since the initial observation, the biological actions
ofTRH on GH cells have been further character-
ized (for a review, see reference 23) . Chronic treat-
ment of GH cells (longer than 4 h) with TRH
stimulates the biosynthesis of prolactin and in-
hibits the rate of growth hormone production (10,
31) . TRH appears to modulate the rates of hor-
mone biosynthesis by regulating the concentra-
tions of prolactin and growth hormone mRNA's
and not by altering the rate of translation of
preexisting mRNA (11, 14, 15) . In addition to
these chronic actions, TRH acutely (within 30
min) stimulates the release- of previously synthe-
sized intracellular prolactin and growth hormone
(12, 24) . In contrast to these stimulatory effects of
TRHonGH cells, thehypothalamic tetradecapep-
tide somatostatin hasbeenshown to inhibit acutely
prolactin and growth hormone release and the
production of both hormones during chronic treat-
ment (27). Specific high-affinity receptors forboth
TRH and somatostatin have been characterized,
and there is strong evidence that these receptors
mediate the biological actions of both hypotha-
lamic peptides on GH cells (18, 19, 27) .
'Abbreviations used in thispaper: EGF, epidermalgrowth
factor; FGF, fibroblast growth factor ; 1`10', Ham's F l0
medium supplemented with 15% horse serum and 2.5%
fetal calf serum ; Fl0 Ih, Ham's F10 medium supple-
mented with 5 mg/ml lactalbumin hydrolysate ; GH,
growth hormone ; hCG, chorionic gonadotropin ; MSA,
multiplication stimulating activity ;TRH, thyrotropin-re-
leasing hormone .
In this paper we demonstrate that hormone
production by GH cells is also regulated by epi-
dermal growth factor (EGF), a protein whose
physiological role is not yet understood (for re-
views, see references 8 and 16). The most thor-
oughly documented biological action of EGF is
stimulation of cell proliferation in epidermal and
epithelial tissues in animals and in several non-
transformed and transformed cell types in culture.
In contrast to the growth stimulatory effects ob-
served with most cells, we have found that low
concentrations ofEGF inhibit the proliferation of
GH cells . At thesame time,EGF alters specifically
the production of prolactin and growth hormone,
and these effects are qualitatively similar but
quantitatively greater than the effects ofTRH. A
preliminary report of some of these results has
been presented (footnotes 2 and 3) .
MATERIALS AND METHODS
Hormones and Growth Factors
Mouse EGF, bovine fibroblast growth factor (FGF) and
multiplication stimulating activity (MSA) were purchased from
Collaborative Research Inc. (Waltham, Mass.). Bovine insulin
was obtained from Calbiochem-Behring Corp., American
Hoechst Corp . (San Diego, Calif) . Synthetic TRH was a gift
from Abbott Diagnostics, Diagnostics Products (North Chicago,
111 .) .
Cell Culture
The properties of GH,C, rat pituitary cells and the methods
of their culture have been described (28, 33, 23) . All other cell
strains utilized were grown under the same conditions asGH 4C,
cells.
Cell culture experiments were performed using replicate 35-
mm dishes (Falcon Labware, Div . of Becton, Dickinson& Co .,
Oxnard, Calif .) inoculated simultaneously with equal aliquots of
cells from a single donor culture and grown under identical
conditions. Cultures were generally inoculated at a density of0.5
to 2 x 10' cells/35-mm dish and grown as monolayers in Ham's
F 10 medium (Grand Island Biological Co., Grand Island, N.Y.)
supplemented with 15% horse serum and 2.5% fetal calf serum
z Tashjian, A. H., Jr ., A. Schonbrunn, and T. F. J .
Martin . 1978 . Program of the Sixth Cold Spring Harbor
Conference on Cell Proliferation, Hormones and Cell
Culture . Cold Spring Harbor Laboratory, Cold Spring
Harbor, N . Y. 35 .
' Schonbrunn, A., M. Krasnoff, M. E . Lomedico, and A.
H. Tashjian, Jr. 1979 . Program of the 61st Meeting of
The Endocrine Society . The Endocrine Society, Be-
thesda, Md . 80.
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air. The culture medium (1 .5 ml/dish) was changed every34 d .
Compounds to be added to cultures were diluted in F10', steri-
lized by filtration through Millipore filters (Millipore Corp.,
Bedford, Mass.), andadded in a volume of 10-20 lal .
Measurement of Cell Proliferation
For growth experiments, cells were plated at a density of 10'-
10'' cells/35-mm dish in 1 .5 ml of F10' . After 24-72 h, the
medium was aspirated to remove unattached cells and replaced
with fresh 1710' containing either no additions or 10 -"M EGF
or 10 -'MTRH. This protocol eliminated any effects on plating
efficiency . Themedia and peptides were renewed every 2-4 d as
described in Results . Replicate dishes were incubated with 0.05%
trypsin (Worthington Biochemical Corp ., Freehold,N. J.), 0.02%
EDTA in Earle's basal salt solution, and the harvested cells were
resuspended in F10' . Thenumber of cells in the suspension was
determined with an electronic particle counter (Coulter Electron-
ics Inc ., Hialeah, Fla. ; model ZBI). Foreach point, cells harvested
from triplicate dishes were counted . The standard deviation did
not exceed ±5% of themean . In four independent experiments,
10 -" M EGF inhibited cell proliferation by 37 ± 11% (mean ±
SD), whereas 10-'MTRH inhibited cell proliferation by 18 ±
7%.
To determine the cell volume within a treatment group, cells
harvested from triplicate dishes were pooled and spectra of cell
volume distributions wereobtained from a multichannel analyzer
(Coulter Channelyzer) connected to an X-Y recorder . Total
counts of -10' cells were accumulated in each spectrum . The
validityof cell volume measurements withaCoulterspectrometer
has been demonstrated by Anderson and Petersen (2) .
To study cellular morphology, photographs ofliving cells were
taken with an inverted phase-contrast microscope (Nikon) at x
200 .
Protein Determination
Alkali-soluble cell protein was determined by the method of
Lowry et al . (22) using bovine serum albumin as a standard .
DNA Determination
Theamount ofDNA per dish was measured by a fluorometer
assay modified from Thomas and Farquhar(34) . Cells from each
dish were suspended in 1.8 ml of0.05M KH 2PO 4 buffer, pH 7.5,
and freeze-thawed two times to disrupt the cells. Trichloroacetic
acid wasadded to the cell suspension to a final concentration of
10% . Aliquots containing 1-10 lag ofDNA were distributed to
siliconized IO x 75-mm test tubes. Bovine serum albumin (100
hg) wasadded to each sample, and the pellets were collected by
centrifugation at 4°C. Each pellet was washed two times with
cold 5% trichloroacetic acid and once with 50mM sodium acetate
in 95% ethanol and then dried at 60'C for 2 h . Recrystallized,
charcoal-purified 3,5-diaminobenzoic acid (20 lal of a40% wt/
vol aqueous solution) (Aldrich Chemical Co., Inc ., Milwaukee,
Wis.) was added and the samples were incubated for 45 min at
60°C . After addition of 0.5 ml of 1.0 N HCI, fluorescence was
measured on a Turner Model III fluorometer (Turner Associates,
Div . ofAm . Sterilizer Co ., Palo Alto, Calif .) equipped with a
Corning type 405 primary filter (Corning Glass Works, Science
Products Div ., Corning, N. Y.) and a Corning 65 A secondary
filter.DNAsamples from each dish were assayed at twodilutions
in duplicate . Calf thymus DNA(Sigma Chemical Co ., St . Louis,
Mo.) was used as standard .
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Measurement ofHormone Secretion
To determine the chronic effects of EGF on hormone pro-
duction, replicate 35-mm dishes were incubated at 37'C in FIO'
with or without EGF for 24-72 h . Medium was collected and
any floating cells were removed by centrifugation for 10 min at
5,000g at 4°C. The supernatant medium was stored at -20'C
for subsequent measurements ofprolactin and growth hormone .
No significant degradation of prolactin occurs either intracellu-
larly or in the medium, and the amount ofprolactin accumulated
in the medium during these long-term incubations is a measure
of de novo synthesis of the hormone (23).
To determine the acute effects of EGF on the release of
presynthesized prolactin, each dish was washed two times with
1.5 ml of Ham's 1`10 medium supplemented with 5 mg/ml
lactalbumin hydrolysate (F10 lh), then 2 ml of preequilibrated
F10 lh medium withorwithoutEGFwasadded. Afterincubation
of cultures at 37'C in a C0 2-air incubator for 30 min, medium
was collected, any floating cells were removed by centrifugation,
and the supernatant medium was stored at -20°C. Pulse-labeling
experiments with GH cell cultures have shown that newly syn-
thesized prolactin exhibits a lag of -" I h before appearing in the
medium (10), indicating that the bulk of the hormone collected
during a 30-min incubation period consists of previously stored
and not newly synthesized hormone .
The amount of prolactin and growth hormone accumulated
in medium was measured by specific quantitative microcomple-
ment fixation immunoassays using baboon antiserum to ratGH
and rabbit antiserum to rat prolactin (29, 30) .
RESULTS
Action ofEGF on Cell Proliferation
The data in Fig. 1 illustrate the effect of EGF
on the growth of GH,C i cells . 3 d after plating,
any unattached cells were removed and fresh me-
dium without or with 10'M EGF was added .
Cells were grownwithout furthermedium changes
until cell proliferation ceased as a result of ex-
haustion of medium nutrients . Cells in control
medium increased in number 2.8-fold during the
4-d incubation, whereas EGF-treated cells in-
creased only 1.7 fold (Fig. 1, top) . Net DNA
synthesis was decreased in EGF-treated cells in
parallel with cell multiplication (Fig . 1, bottom) .
AverageDNA per cell was 11 pg for both control
and EGF-pretreated cultures .
The results shown in Fig . 2 demonstrate that
EGF not only inhibited the rate of cell prolifera-
tion but also decreased the plateau cell density .
Cells were plated at two densities differing by a
factor of ten, and allowed to attach to culture
dishes. Half the cultures were then treated with
10-8 M EGF, the remaining cultures were incu-
bated with medium lacking EGF. Cells grown in
the absence of EGF had an average population
doubling time of 36 h, whereas cells grown in the
presence ofEGF had an average doubling time ofh.
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FIGURE 1 Effects of EGF on cell proliferation and
DNAcontent . GH,C, cells were plated at a density of 5
X 10' cells/35-mm dish in 1 .5 ml F 10' . 3 d after plating,
cells were fed with fresh medium with (O) or without
(41) 10-eM EGF. Cultures were incubated without fur-
ther medium changes and dishes were harvested every
24 h . Cell number/dish (top panel) and cellular DNA/
dish (bottom panel) were determined for replicate dishes
as described in Materials and Methods. Each point rep-
resents the mean of duplicate dishes and the bars show
the range.
46 h. In the presence of EGF, cultures reached a
plateau density of 3 x 106 cells/dish, 66% of the
final densityreachedby control cultures (4.5 x 106
cells/dish) . The plateau density reached was not
limited by the depletion of nutrients from the
medium, since no net increase in cell number
resulted when fresh growth medium was added .
It is important to emphasize that these inhibi-
tory effects of EGF were not caused by a toxic
effect on the cells . Addition of EGF to GH,C,
cells never resulted in a loss of cells ; only the rate
of increase of the cell population was altered.
When EGF was added to cultures in the plateau
phase of growth, no change in cell number was
observed.
When cells grown in the presence ofEGF were
transferred to medium lacking EGF, the rate of
cell proliferation increased and EGF-pretreated
cells attained the same density as cultures never
previously exposed to EGF(Fig . 2) . Therefore, the
inhibitory effect of EGF was reversible both for
cultures that had reached a plateau density (Fig.
2, open triangles) and for cultures that were still in
the log phase of cell division (Fig . 2, open circles) .
EGF Increases Cell Size and
Alters Cellular Morphology
Fig . 3 shows the appearance of cultures grown
to high density in thepresence or absence ofEGF .
Cells grown in the absence ofEGF were spherical
and loosely adherent to the substratum (Fig . 3A) .
Two types of cellular morphology were observed
in cultures grown in the presence ofEGF. Most of
the cells were elongatedand flattenedwith angular
borders (Fig . 3B) whilesome, although larger than
control cells, retained their rounded shape (Fig.
3C . The appearance of EGF-treated cells was
reminiscent of the previously described effects of
TRH on GH cell morphology (32), and Fig . 3D
and E show the appearance of TRH-treated cells
in the same experiment for comparison. Again,
both enlarged rounded cells and elongated, flat-
tened, angular cells were observed .
The presence of two types of cellular morphol-
ogy in GH cell cultures is not a reflection of cell
heterogeneity within the population . Time-lapse
FIGURE 2 Effects of EGF on the proliferation of
GH 4C, cells . GH,C, cells were plated at a density of 10'
cells/35-mm dish (A, A), or 10 ° cells/35-mm dish (" ,
O) in l.5 ml of F 10' . 1 d after plating, cultures were fed
with fresh medium with (0,O) or without (A,") 10-"M
EGF. Replicate dishes were harvested every 48 or 72 h
as shown and fresh medium with or without EGF was
added to the remaining dishes . After 10d(shown by the
arrow) some of the cultures treated with EGF were
switched to control medium (X) . Cell number was deter-
mined as described in Materials and Methods . Each
point represents the mean value of triplicate dishes . The
standard deviations did not exceed ±5% of the mean
values shown .
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presence and absence ofEGF orTRH . GH,C, cells were
plated at a density of 5 x 104 cells/35-mm dish in 1.5 ml
of 1710' . 3 d after plating, cultures were fed with fresh
media without any additions (A) or with 10- ' M EGF
(B and C) or l0-'MTRH (D and E) added. The media
were renewed every 3 d, and fresh EGF and TRH were
added . On day 10, the living cells were photographed
under phase contrast (x 200) . Control dishes contained
1 .3 f 0.04 x 10`' (mean t SD) cells/dish. EGF-treated
dishes contained 8.2 t 0.03 x 10' cells/dish . TRH-
treated dishes contained 8.3 t0.12 x 10' cells/dish . The
data in Fig . 4 give the cell size distribution for this
experiment .
photography of living GH cells under phase-con-
trast optics has shown that a single cell can spon-
taneously change from a rounded morphology to
a flattened, angularshape . In control cultures, cells
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are rounded most of the time ; therefore a still
photograph of a culture shows >90% of the cells
to be spherical . In contrast, EGF- and TRH-
treated cells remain flat and angular most of the
time . Therefore a photograph of treated cultures
shows most of the cells to be stretched . GH cells
are thus able to assume two different morpholo-
gies . EGF and TRH shift the prevalent morphol-
ogy of the population presumably by altering the
fraction of time each cell assumes a particular
shape .
To determine whether the apparent increase in
cell size detected by microscope observation was
caused by a real increase in cell volume or merely
the result of cell stretching, cells were detached
from dishes, and cell volume was determined by
electronic counting. The results, shown in Fig. 4,
demonstrate thatEGF, and to a lesser extentTRH,
produce highly significant increases in mean cell
volume.
The effect ofEGF on cell volume was reversible
as was its effect on cell proliferation . 4 d after
cessationofEGFtreatment, mean cell volume had
decreased substantially although cell number was
thesame as for cultures continued in the presence
of EGF (Table I, Day 14) . 7 d after cessation of
EGF treatment, mean cell volume was indistin-
guishable from that of control cells even though
cell number had not yet reached the same value as
cells never previously exposed to EGF (Table 1,
Day 17) .
CELL VOLUME (pM5l
FIGURE 4 Effect of EGF and TRH on cell volume .
Cells from the experiment described in Fig . 3 were
detached from dishes with trypsin as described in Ma-
terials and Methods. Cell volume distribution was deter-
mined by electronic counting. The mean cell volume of
control, TRH-treated, and EGF-treated cells was 380,
560, and 740 dam', respectively .TABLE I
Reversibility ofEGFAction on Cell Volume and
Cell Number
GH,C I cells plated at a density of 10 4 cells/35-mm dish
were treated as described in Fig. 2 .On days 14 and 17,
cell volume and cell number were determined for
control cultures, cultures treated with 10-a MEGF for
the entire experiment (EGF), and cultures treated for
10 d with 10-"MEGF and then transferred to control
medium (EGF~ control) .
* Mean ± SD of triplicate dishes .
TRH Also Decreases
Cell Proliferation
The qualitative similarity between the effects of
EGF and TRH on cellular morphology and size
prompted us to reexamine the effect of TRH on
cell proliferation . Tashjian et al . (31) had previ-
ously shown that chronicTRH treatment did not
affect total cell protein perdish in cultures ofGH 3
cells . The results in Fig . 5 demonstrate that neither
TRH nor EGF significantly altered total cell pro-
tein per dish in cultures ofGH4C1 cells . However,
in the same experiment, EGF caused a 30% inhi-
bition and TRH caused a 10% inhibition in cell
number per dish after6d. Therefore, a net increase
in protein content per cell occurred with both
EGF- and TRH-treated cultures .
TRH andEGF together had a greater effect on
cell proliferation than either peptide alone, result-
ing in a 45% decrease in the number of cells per
dish (Fig . 5) . This additive effect was also observed
when cell volume was measured . The results in
Table II demonstrate that treatment of GH 4C l
cells for 3 d with TRH resulted in a 15% increase
in cell volume, treatment with EGF caused a70%
increase, while both peptides together caused a
94% increase .
EGF Modulates Hormone Production
TRH has previously been shown to stimulate
prolactin synthesis and inhibit GH production by
GH cells (23). Because the effects of EGF and
TRH on cell proliferation and morphology were
similar, we examined the effects of EGF on hor-
mone production . The results in Fig. 6 demon-
strate that EGF stimulated prolactin synthesis
markedly and inhibited growth hormone produc-
tion . The amount ofprolactin that accumulated in
the medium of EGF-treated cultures was eightfold
greater than in control cultures after 3 d of treat-
ment . In the same experiment, growth hormone
was reduced to 35% of control after 3 d .
We next examined whether EGF andTRHhad
additive effects on hormone production as they
did on cell proliferation and cell volume . GH4Cl
cells were incubated in controlmedium br medium
containing 10-'M EGFalone, 10-'MTRH alone,
or both peptides . Medium samples were collected
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FIGURE 5
￿
Effect ofEGFandTRHon cell proliferation
and cell protein. GH,C t cells were plated at a density of
105 cells/35-mm dish . 3 d after plating, cultures were fed
with fresh media lacking any additions (O) or containing
l0-' M TRH ("), 10-e M EGF ("), or both peptides
(N). Replicate dishes were harvested every2 d, and fresh
medium with or without the peptides was added to the
remaining dishes. Cell number (top panel) and total cell
protein (bottom panel) per dish were determined as
described in Materials and Methods. Each point gives
the mean value of triplicate dishes . The standard devia-
tion did not exceed t5% of the mean for cell number
determinations and f10% of the mean for protein meas-
urement . The data in Fig . 7 show hormone production
in this experiment .
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Treatment Cell volume Cell No ./dish*
X101
Day 14
Control 320 1 .8 t 0.07
EGF 510 1 .2 t 0.03
EGF~ control 430 1 .3 ± 0.05
Day 17
Control 320 2.6 ± 0.05
EGF 500 1 .7 t 0.03
EGF ---> control 320 2.3 ± 0.05TABLE Il
AdditivityofEffects ofSupramaximal Concentrations
ofEGF and TRH on Cell Volume and Cell Number
GH4C I cells were plated at a density of 1 .4 x 10' cells/
35-mm dish in 1 .5 ml of F10' . 3 d after plating, cells
were fed with fresh medium containing the peptides
shown . After 3 d of treatment, cell volume and cell
number were determined as described in Materialsand
Methods .
* Mean ± SD of triplicate dishes.
every 48 h and assayed for prolactin and growth
hormone . The effects of EGF on hormone pro-
duction were much greater than those of TRH
(Fig. 7) . Prolactin synthesis per culture was stim-
ulated two- to threefold by TRH, whereas EGF
increased the synthesis of prolactin five- to nine-
fold . These effects were even greater when calcu-
lated on a per cell basis . After 6 d of treatment
with EGF, prolactin synthesis per cell was in-
creased 12-fold . When TRH andEGF were pres-
ent simultaneously for 6 d, prolactin synthesis per
culture was increased 12-fold whereas synthesis
per cell was 23-fold higher than for untreated
control cells . Thus, the effects of TRH and EGF
on prolactin synthesis were additive .
In the experiment described in Fig . 7, TRH
alone caused a 15% decrease in growth hormone
production after 6 d, whereas EGF caused a 40%
decrease . These inhibitory effects on growth hor-
mone production were similar in magnitude to the
inhibition of cell proliferation (Fig . 5), such that
growth hormone per cell was only marginally
altered by TRH or EGF in this experiment. In
most experiments, however, EGF did cause a net
decrease in growth hormone production per cell
(e.g ., Fig . 8) . Because TRH treatment caused a
rather small decrease in growth hormone produc-
tion in the experiment shown in Fig. 7, it is not
clear whether the effects of TRH and EGF on
growth hormone were additive, as they were on
prolactin production .
The concentration dependence of the effects of
EGF on cell proliferation and hormone produc-
tion by GH 4C I cells is shown in Fig . 8 . The dose-
response curves for inhibition ofcell proliferation,
stimulation of prolactin synthesis, and inhibition
of GH production are similar with half-maximal
effects occurring at -5 x 10-"M. In three inde-
pendent experiments the Kapp observed for these
biological effects ofEGF was 4.0 ± 2.3 x 10-"M
(mean± SD) .
Effects of Growth Factors Other
Than EGF on GH4CI Cells
To determine whether the effect of EGF on
hormone production and cell proliferation by
GH4CI cells was specific to this growth factor, the
experiments described in Fig . 9and Table IIIwere
performed . Although neither insulin normultipli-
cation stimulating activity (MSA) altered prolactin
synthesis after 3 d of treatment, both EGF and
792
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 85, 1980
HOURS
FIGURE 6 Effects of EGF on prolactin and growth
hormone production . GH,C I cells were plated at a den-
sity of 10~' cells/35-mm dish in 1.5 ml ofF10' . 5 d after
plating, cultures were fed with fresh F 10' with (O) or
without (") 10-" M EGF . Cells were grown without
further medium changes . Media from replicate dishes
were harvested at the times shown and the content of
prolactin (top panel) and growth hormone (bottom
panel) was determined as described in Materials and
Methods . Each point gives the mean value of duplicate
dishes and the bars show the range .
Treatment Cell volume
tun
Cell No./dish"
X10 1
Control 340 10 .3 ± 0.08
EGF, 10 -'M 570 7.4 ± 0.12
TRH, 10-7M 390 7.6 ± 0.04
EGF and TRH 660 6.8 ± 0.17\' o,
y
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FIGURE 7
￿
Effect ofEGF alone, TRH alone, and EGF
plus TRH on hormone production. GH 4C 1 cells were
plated at a density of 10' cells/35-mm dish . 3 d after
plating, cultures were fed with fresh media without any
additions (0) or containing l0-7 M TRH (A), l0-" M
EGF (0), or both peptides (0) . Medium from replicate
dishes was harvested every 48 h, and fresh medium with
or without the peptides was added to the remaining
dishes . The content of prolactin (top panel) and growth
hormone (bottom panel) was determined for each 48-h
collection as described in Materials and Methods. Each
point gives themean value ofduplicate dishes. Therange
did not exceed ±l0% of the mean value . Fig. 5 shows
cell number and total cell protein for this experiment .
FGF caused a significant stimulation (Fig. 9) . In
the same experiment, FGF decreasedGH produc-
tion by 16% whileEGF caused a 25% inhibition .
Table III shows that FGF also increased cell
volume and decreased cell proliferation and that
the magnitude of these changes was again smaller
than that caused by EGF. Insulin and MSA had
no effect on cell growth or cell volume . Therefore
the actions ofEGFon GH 4C, cells are not entirely
unique to this growth factor, as FGF had quali-
tatively similar effects, though of smaller magni-
tude . However, not all growth factors mimic the
actions ofEGF.
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FIGURE 8
￿
Concentration dependence of EGF effects
on cell proliferation and prolactin and growth hormone
production by GH4C, cells . GH4C, cells were plated at
a density of 3 x 10 4 cells/35-mm dish . 4 d after plating,
fresh 1`10' containing the indicated concentrations of
EGF was added . After 3 d of incubation, the medium
was renewed and fresh EGF was added . After three
additional days of incubation, cell number per dish (top
panel) was determined as described in Materials and
Methods . Media from the last 3 d of incubation were
collected and assayed for prolactin (middle panel) and
growth hormone (bottom panel) . Each point gives the
mean value of triplicate dishes and the bars show the
standard deviation .
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FIGURE 9
￿
Effects of different growth factors on pro-
lactin production by GH 4C, cells. GH 4C, cells were
plated at a density of 1 .4 x 10' cells/35-mm dish. 3 days
after plating, cultures were fed with fresh medium con-
taining either no additions or EGF (l0-t' M), FGF (10-e
M), insulin (10-' M), or MSA (l .5 x 10-" M) . After 3 d,
media were collected and prolactin was determined as
described in Materialsand Methods . Each bar gives the
mean value of triplicate dishes and the brackets show the
standard deviation . Table III gives the cell numbers per
dish for this experiment .
Cell Specificity ofEGF Effect
on Hormone Production
To test the specificity of EGF action on GH4C,
cells, we examined the abilityofEGF to modulate
hormone production by several clonal pituitary
tumor cell strains (Table IV) . GH3, GH,2C,, and
GC are clonal strains ofpituitary cellswhich were
derived from the same tumor (MtT/W5) as the
GH 4C, cell strain (23) . These strains secrete dif-
ferent relative amounts of growth hormone and
prolactin. GC and GH,2C, cells secrete large
amounts of growth hormone but no detectable
prolactin, whereas GH4C, and GH3 cells secrete
large amounts of prolactin and lesser amounts of
growth hormone . F4C1 cells were derived from a
different pituitary tumor (MtT/F 4 ) than the GH
cell strains and synthesize large amounts of pro-
lactin and relatively little growth hormone (25) .
For all the strains tested, EGF stimulated prolactin
synthesis and decreased growth hormone produc-
tion. However, not all pituitary cells responded to
EGF with altered hormone production . AtT20/
D16 cells are a clonal strain of mouse pituitary
cells that secrete ACTH (26) and endorphin (1) .
EGF had no effect on ACTH production by
AtT20/D16 cells .
We have examined each of these pituitary cell
strains for the presence of specific EGF receptors
and have found that only the AtT20/D16 cells
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lack receptors : all the other pituitary cell strains
shown in Table IV have saturable, high-affinity
binding sites for 125I-EGF (A . Schonbrunn andA.
H. Tashjian, Jr ., manuscript in preparation) .
Therefore, there is a close correlation between the
presence ofEGF receptors and the ability ofEGF
to modulate hormone production.
Effect ofEGF on Prolactin Release
Because TRH has been shown to stimulate
acutely the release of stored intracellular prolactin
from GH cells, as well as to increase prolactin
synthesis during chronic treatment (12), the ability
ofEGF to modulate prolactin release wasstudied .
The results in Fig. 10 show that EGF caused a
small but significant stimulation of prolactin re-
lease during a 30-min incubation. However, in
contrast to the relative magnitude of theTRH and
EGF effects in modulating chronic hormone pro-
duction, EGF was less effective at stimulating
prolactin release thanTRH. In fact, in experiments
in whichtheTRH effect on release was small (less
than a 50% increase), we often were unable to
detect a significant effect of EGF on prolactin
release . Therefore, although the effects of EGF
andTRHon GH 4C1 cells are qualitatively similar,
the power of their different biological actions is
not identical .
DISCUSSION
EGF stimulates the proliferation of epidermal and
epithelial tissues in animals and enhances cell
proliferation in culture fora variety of transformed
TABLE III
Effects of Different Growth Factors on Proliferation
and Cell Volume ofGH4C, Cells
GH4C, cells were plated at a density of 1.4 x l0' cells/
35-mm dish . 3 d after plating, cultures were fed with
fresh medium containing the peptides shown . After
three additional days of incubation, cell number and
cell volume were determined as described in Materials
and Methods. Fig. 9 shows prolactin production for
these cultures .
* Mean ± SD oftriplicate dishes .
Treatment Cell volume Cell No ./dish*
14m , x/0"
Control 340 10 .5 ± 0.31
EGF, 10-'M 460 8.0 ± 0.02
FGF, 10-'M 400 9.2 ± 0.20
Insulin, 10 -'M 340 10.0±0.30
MSA, 1.5 x 10-3M 330 9.8 ± 0.36TABLE IV
Effects ofEGF on Hormone Production by D~fferent Pituitary Cell Strains
and nontransformed cell types (8) . The new results
presented in this paper raise the possibility that
EGF may have important biological actions not
related directly to mitogenesis . EGF and TRH, a
hypothalamic-releasing hormone, act similarly on
GH4C, cells, a clonal strain of functional rat pi-
tuitary cells . Both peptides increased the release
and synthesis of prolactin and inhibited growth
hormone production . TRH was more powerful at
stimulating acute prolactin release. EGF had
larger effects on chronic hormone production .
These actions of EGF occurred at low concentra-
tionsofthepolypeptide ; half-maximal stimulation
of prolactin synthesis and inhibition of growth
hormone production were observed with 5 x l0-"
M EGF (Fig. 8) . The plasma concentration of
EGF in the adult mouse is - 1.5 ng/ml (7) and the
concentration ofhEGF or urogastrone in human
plasma is 2-4 ng/ml (9). Comparable concentra-
tions ofEGF are likely to be present in rat body
fluids as well . Thus, the concentrations ofEGF in
the circulation (-2.5 x 10- '° M) are sufficiently
high that EGF could play a role in regulation of
pituitary hormone synthesis and secretion in the
intact animal . In an entirely different tissue, Ben-
veniste et al . (4) have also found effects of EGF
on hormone production . These workers showed
Cells at high density were treated for 3 d without or with 2 x 10-"MEGF . At theendofthe
incubation, media were collected and assayed for hormones as described in Materials and
Methods. Statistical significance wasdetermined from a t test of paired data using a pooled
residual error for the entire experiment.
Mean ± SD of triplicate dishes .
$ ACTH was measured by radioimmunoassay following the procedure of Eipper and Mains
(13) .
that addition of EGF to cultured human chorio-
carcinoma cells stimulated the production of cho-
rionic gonadotropin (hCG) and to a lesser extent
the production of free hCG-a subunits.
The striking similarity between the actions of
EGF andTRH on GH4C, cells raises thequestion
as to whether EGF is also synthesized in the
hypothalamus . The tissue distribution of immu-
noreactive EGF has been studied in both the
mouse (6) and the human (20) . In both studies,
EGF concentration wasbelow detectable levels in
brain and pituitary tissue . However, even if the
hypothalamus was a major source of EGF, its
presence might not have been detected in studies
in which the content of whole brain wasmeasured .
EGF has been found throughout the gut and,
because many hypothalamic peptides have been
shown to be present in gastrointestinal tissue, it
would not be unexpected to discover a similar
distribution for EGF.
The inhibitory effect of EGF on the multipli-
cation ofGH4C1 cells was surprising because with
most cell types it either increased the rate of cell
proliferation or had no effect (8) . The concentra-
tion ofEGF that caused a half-maximal inhibition
of cell proliferation by GH4C 1 cells (5 x 10-" M)
was in the same range that caused stimulation of
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Cell type Hormone assayed
Hormone
Control
production`
EGF P value
Eglmtl77 h
GH4C, Prolactin 20± 0.4 36 ± 1 .3 <0.001
GH 3.5 ±0.06 1 .7 ±0.07 <0.001
GH;, Prolactin 22 ±0.5 39 ±0.9 <0.001
GH 2.2±0.07 1.3±0.02 <0.01
F4C, Prolactin 19 ± 1 .0 25 ± 0.40 <0.001
GH 12C, GH 7.5 ± 0.40 5.5 ± 0.39 <0.001
GC GH 13±0 .6 Il ±0 .5 <0.001
AtT20/D 16 ACTH$ 0.10 ± 0.010 0.10 ± 0.008 >0.050
Control EGF TRH
FIGURE 10
￿
Effect ofEGF on prolactin release . GH,C t
cells were incubated with 2 ml of F 10 III containing
either no additions (control) or l0-B M EGF or 10-7M
TRH . Media were collected after 30 min of incubation
at 37°C, and prolactin was determined as described in
Materials and Methods . Each bar gives the mean value
of duplicate dishes and the brackets show the ranges .
Cell proteinwas0.40 mg/60-mm dish .
fibroblast cell proliferation (8, 16) . It is not known
whether this inhibition of cell proliferation or the
effect on hormone production constitutes the pri-
mary physiological action of EGF on pituitary
cells. It is interesting in this regard that TRH also
inhibited the proliferation of GH 4C I cells . Al-
though we found that TRH had no effect on total
cell protein per culture, in agreement with the
original observations of Tashjian et al . (3 l), this
result gives an incomplete view of effects on cell
proliferation . In fact, treatment of cultures with
TRH does result in asmall but significant decrease
in cell number and DNA. Therefore, changes in
cell size and protein content per cell can result in
incorrect conclusions when protein content of cul-
tures alone is used as the measure of cell growth .
Not all growth factors affect GH4CI function :
neitherMSA nor insulin altered prolactin produc-
tion, cell proliferation, or cellular morphology .
However, the results in Table III demonstrate that
FGF, also a potent mitogen for certain cell types
(16), had qualitatively similar effects on GH4CI
cells as EGF and TRH. The inhibitory effect of
FGF on cell proliferation was particularly surpris-
ing since Hayashi et al . (17) have reported that
FGF increased the proliferation of GH a cells, the
cell line from which GH 4CI cells were originally
7%
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derived . The experiments of Hayashi et al . were,
however, performed in chemically defined me-
dium lacking serum . The role of serum factors in
determining the proliferative and hormonal re-
sponses of GH cells to FGF and to EGF clearly
requires further investigation .
Almost 10 yr ago, Tashjian et al . reported the
unexpected observation that crude acid extracts of
bovine liver, kidney and cerebral cortex, as well as
hypothalamus, caused a 6- to 10-fold increase in
prolactin synthesis by GH3 cells, accompanied by
a 50% decrease in growth hormone production (30,
32) . There was no concomitant change in total cell
protein per dish ; however, the tissue extracts did
alter the morphology of the cells from rounded to
highly stretched . The active material in liver ex-
tracts had a mot wt >10,000 and was heat-labile,
losing most of its biological activity after 10 min
at 60°C (3) . The identity of the active principle
remains to be defined ; however, the similarity
between its properties and those of FGF would
indicate that this growth factor is a possible can-
didate molecule .
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